XENE
XENE
CA98420N1050
Xenon Pharmaceuticals Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 7.500.000 --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
380.570.000 279.298.000
36.3%
Operating Income -373.070.000 -279.298.000
33.6%
Pretax Income -344.894.000 -238.419.000
44.7%
Net Income Common Stockholders -345.910.000 -234.330.000
47.6%
-- --
--
-- --
--
ende